Aptar Digital Health, a division of Aptar Pharma (part of AptarGroup, Inc.), provides end-to-end digital health solutions for pharmaceutical and biotech companies. The platform is built on a holistic ecosystem of digital interventions, combining mobile/web applications, connected drug delivery devices, and a secure, compliant data platform to enhance patient experiences and improve health outcomes.
Core Offering and Benefits:
- Digital Therapeutics (SaMD): Development of regulated Software as a Medical Device solutions (like Oleena® for oncology symptom management) and non-regulated Digital Patient Support Programs (PSPs) (like MigraineBuddy) to empower patients in self-managing their conditions.
- Connected Devices: Integration with a broad range of connected drug delivery systems (inhalers, injectables, nasal sprays) via technologies like Bluetooth, NFC, and Direct-to-Cloud data management. These devices offer features like dose reminders and adherence monitoring.
- Disease Management Platform: A comprehensive suite of products and services that aggregates all data flows into a single, accessible system for patients and healthcare providers, supporting the entire treatment journey from prevention and diagnosis to ongoing management.
Key Features and Capabilities:
- Software as a Medical Device (SaMD) development
- Connected Drug Delivery Systems (Inhalers, Injectables, Nasal Sprays)
- Patient & Caregiver Mobile Applications
- Remote Patient Monitoring (RPM) and ePROS (Electronic Patient Reported Outcomes)
- Real-Time Data Analytics & Reporting for care teams
- Medication Adherence Monitoring & Dose Reminders
- Symptom and Trigger Tracking
- Telehealth & Virtual Care Solutions
- Training and Onboarding Services
Target Market and Use Cases:
- The primary target is global Pharmaceutical and Biotech Companies seeking to differentiate their drug products and improve patient adherence and outcomes.
- Use Cases cover a wide range of therapeutic areas, including Respiratory (Asthma, COPD), Oncology, Neurology (Migraine), Diabetes, Cardiovascular, and CNS.